Goldman Sachs’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32M | Sell |
116,534
-86,286
| -43% | -$1.72M | ﹤0.01% | 3320 |
|
|
2025
Q1 | $3.43M | Buy |
202,820
+45,279
| +29% | +$765K | ﹤0.01% | 3004 |
|
|
2024
Q4 | $2.91M | Buy |
157,541
+29,818
| +23% | +$551K | ﹤0.01% | 3250 |
|
|
2024
Q3 | $2.78M | Buy |
127,723
+28,746
| +29% | +$625K | ﹤0.01% | 3135 |
|
|
2024
Q2 | $1.94M | Buy |
98,977
+15,207
| +18% | +$298K | ﹤0.01% | 3212 |
|
|
2024
Q1 | $1.82M | Sell |
83,770
-18,642
| -18% | -$405K | ﹤0.01% | 3258 |
|
|
2023
Q4 | $2.96M | Sell |
102,412
-1,290
| -1% | -$37.3K | ﹤0.01% | 2953 |
|
|
2023
Q3 | $2.77M | Sell |
103,702
-28,113
| -21% | -$752K | ﹤0.01% | 2885 |
|
|
2023
Q2 | $4.88M | Buy |
131,815
+60,820
| +86% | +$2.25M | ﹤0.01% | 2585 |
|
|
2023
Q1 | $2.22M | Buy |
70,995
+20,530
| +41% | +$641K | ﹤0.01% | 3140 |
|
|
2022
Q4 | $1.5M | Sell |
50,465
-25,097
| -33% | -$747K | ﹤0.01% | 3451 |
|
|
2022
Q3 | $2.88M | Buy |
75,562
+34,157
| +82% | +$1.3M | ﹤0.01% | 3071 |
|
|
2022
Q2 | $2.26M | Sell |
41,405
-76,132
| -65% | -$4.15M | ﹤0.01% | 3343 |
|
|
2022
Q1 | $7.34M | Buy |
117,537
+83,678
| +247% | +$5.22M | ﹤0.01% | 2495 |
|
|
2021
Q4 | $3.41M | Sell |
33,859
-400
| -1% | -$40.2K | ﹤0.01% | 3101 |
|
|
2021
Q3 | $3.08M | Buy |
34,259
+11,663
| +52% | +$1.05M | ﹤0.01% | 3151 |
|
|
2021
Q2 | $2.08M | Buy |
22,596
+5,441
| +32% | +$502K | ﹤0.01% | 3473 |
|
|
2021
Q1 | $1.66M | Buy |
17,155
+5,074
| +42% | +$490K | ﹤0.01% | 3531 |
|
|
2020
Q4 | $630K | Buy |
12,081
+1,927
| +19% | +$100K | ﹤0.01% | 3703 |
|
|
2020
Q3 | $407K | Buy |
+10,154
| New | +$407K | ﹤0.01% | 3767 |
|
|
2020
Q2 | – | Sell |
-31,131
| Closed | -$335K | – | 4426 |
|
|
2020
Q1 | $335K | Buy |
+31,131
| New | +$335K | ﹤0.01% | 3694 |
|
|
2017
Q1 | – | Sell |
-14,167
| Closed | -$164K | – | 4452 |
|
|
2016
Q4 | $164K | Sell |
14,167
-6,833
| -33% | -$79.1K | ﹤0.01% | 3965 |
|
|
2016
Q3 | $194K | Buy |
+21,000
| New | +$194K | ﹤0.01% | 3946 |
|